- By Jackie Connor
- Posted December 14, 2016
Dr. Fergus Couch Talks with Ambry about Recent Study Findings
At Ambry we had the exciting opportunity to talk with Dr. Fergus Couch, Mayo Clinic Researcher, about his involvement with our Mayo Clinic research collaboration. “Breast cancer risks associated with mutations in cancer predisposition genes identified by clinical genetic testing of 60,000 breast cancer patients,” which was the largest hereditary…
- By Jackie Connor
- Posted November 23, 2016
'The Color Violet' Documentary to Premiere at American Epilepsy Society's Annual Meeting
Ambry is proud to introduce “The Color Violet,” a documentary created in collaboration with the PCDH19 Alliance and UCSF Benioff Children’s Hospital. The film explores the life of a 9-year-old girl, Violet McManus, and her family’s collective journey with PCDH19-related epilepsy. The film also explores the latest available treatments…
- By Jackie Connor
- Posted November 16, 2016
Quality Genetic Testing and Why it Matters on Lifetime's 'Access Health' Television
Genetic testing has become an impactful method for clinicians to help their patients confirm their chances of inheriting a genetic disease. Testing quality is an imperative element in determining a patient’s next steps and whether their family members should also be tested. On November 16th, Ambry CEO Aaron Elliott, PhD and Robina Smith, MD,…
- By Jackie Connor
- Posted November 7, 2016
Ambry Execs Discuss the Importance of Genetic Testing on Lifetime's "Access Health" Program
Genetic testing has helped research for breast cancer progress immeasurably, and thanks to some high profile cases, more women are opting for genetic testing when they go in for mammograms and other checkups. As a result, more companies are offering a variety of genetic tests geared towards detecting mutations in the BRCA1 and BRCA2…
- By Jackie Connor
- Posted November 3, 2016
Ambry Supports 'Movember' with Clinical Research, Testing Menu Updates and...Mustaches
The many male faces at Ambry are becoming a little scruffier in support of ‘Movember,’ an initiative dedicated to raising awareness about men’s health. While our guys forgo the barber and/or a daily shave, at Ambry, the meaning behind ‘Movember’ goes deeper than the mustachioed men on campus. Ambry’s constant push for more clinical…
- By Jackie Connor
- Posted November 2, 2016
Watch: What Makes Sanger Confirmation Essential? Find out from Ambry's CEO
In the months following the National Society of Genetic Counselor’s (NSGC) annual conference, Ambry’s paper on Sanger confirmation has made headlines throughout the genetic testing industry and has upended conventional thinking regarding Next generation sequencing. What started as a Sponsored Evening Session presentation at NSGC, has…
- By Jackie Connor
- Posted October 26, 2016
Research Shows BRCA2 may be Linked to Brain Tumors
In 2016, it is estimated that 246,660 new cases of breast cancer will be diagnosed in women and 2,600 cases in men and out of those cases, only about 5-10% will be hereditary. The most common cause for hereditary breast cancer cases are due to mutations in the BRCA1 and BRCA2 genes. Thanks to recent research at Ambry, it is now…
- By Jackie Connor
- Posted October 20, 2016
Ambry Supports Breast Cancer Awareness Month throughout October
In honor of Breast Cancer Awareness month, Ambry is proud to support many non-profit foundations and organizations, including the Mauli Ola Foundation’s 3rd annual Battle for the Breasts (B4TB). The B4TB is an online surf contest featuring 16 professional women surfers who are each paired with cancer clinics and/or foundations. Each surfer…
- By Jackie Connor
- Posted October 19, 2016
What is a Genetic Counselor?
Throughout the healthcare industry, it is known that genetic counselors play a vital role in the care and treatment of patients. Genetic counselors guide patients through the genetic testing journey and provide them and their primary care physician with detailed explanations of their test results. Check out our video that takes potential patients…
- By Jackie Connor
- Posted October 12, 2016
New Study Reflects Need for Genetic Testing for Prostate Cancer Patients
The New England Journal of Medicine (NEJM) recently released a study, which concluded that 11.8% of metastatic prostate cancer cases were caused by germline gene mutations leading to hereditary prostate cancer. The study involved 692 men from the United States and United Kingdom who have documented metastatic prostate cancer. Eighty-four germline…